# Evaluating the Rationality of the International Guideline About Selective Coverage of Level Ib in CTV With NPC

> **NCT04745741** · — · UNKNOWN · sponsor: **Fujian Cancer Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **RADIATION:** IB-positive group

## Key facts

- **NCT ID:** NCT04745741
- **Lead sponsor:** Fujian Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-01
- **Primary completion:** 2021-05-01
- **Final completion:** 2021-06-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04745741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04745741, "Evaluating the Rationality of the International Guideline About Selective Coverage of Level Ib in CTV With NPC". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04745741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*